Last reviewed · How we verify

Magnesium sulphate intramuscular

Nishtar Medical University · FDA-approved active Small molecule

Magnesium sulphate intramuscular is a Anticonvulsant; electrolyte supplement Small molecule drug developed by Nishtar Medical University. It is currently FDA-approved for Seizure prophylaxis and treatment in preeclampsia and eclampsia, Severe hypertension in pregnancy, Arrhythmia management (torsades de pointes). Also known as: MgSO4 intramuscular.

Magnesium sulphate acts as a central nervous system depressant and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and reducing neuromuscular transmission.

Magnesium sulphate acts as a central nervous system depressant and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and reducing neuromuscular transmission. Used for Seizure prophylaxis and treatment in preeclampsia and eclampsia, Severe hypertension in pregnancy, Arrhythmia management (torsades de pointes).

At a glance

Generic nameMagnesium sulphate intramuscular
Also known asMgSO4 intramuscular
SponsorNishtar Medical University
Drug classAnticonvulsant; electrolyte supplement
TargetNMDA receptor; voltage-gated calcium channels
ModalitySmall molecule
Therapeutic areaObstetrics; Neurology; Cardiovascular
PhaseFDA-approved

Mechanism of action

Magnesium sulphate works through multiple mechanisms: it antagonizes NMDA receptors to reduce neuronal excitability, acts as a natural calcium antagonist to decrease acetylcholine release at the neuromuscular junction, and produces vasodilation. These properties make it effective for seizure prophylaxis and management of severe hypertension in obstetric emergencies.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Magnesium sulphate intramuscular

What is Magnesium sulphate intramuscular?

Magnesium sulphate intramuscular is a Anticonvulsant; electrolyte supplement drug developed by Nishtar Medical University, indicated for Seizure prophylaxis and treatment in preeclampsia and eclampsia, Severe hypertension in pregnancy, Arrhythmia management (torsades de pointes).

How does Magnesium sulphate intramuscular work?

Magnesium sulphate acts as a central nervous system depressant and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and reducing neuromuscular transmission.

What is Magnesium sulphate intramuscular used for?

Magnesium sulphate intramuscular is indicated for Seizure prophylaxis and treatment in preeclampsia and eclampsia, Severe hypertension in pregnancy, Arrhythmia management (torsades de pointes), Asthma exacerbation (acute severe).

Who makes Magnesium sulphate intramuscular?

Magnesium sulphate intramuscular is developed and marketed by Nishtar Medical University (see full Nishtar Medical University pipeline at /company/nishtar-medical-university).

Is Magnesium sulphate intramuscular also known as anything else?

Magnesium sulphate intramuscular is also known as MgSO4 intramuscular.

What drug class is Magnesium sulphate intramuscular in?

Magnesium sulphate intramuscular belongs to the Anticonvulsant; electrolyte supplement class. See all Anticonvulsant; electrolyte supplement drugs at /class/anticonvulsant-electrolyte-supplement.

What development phase is Magnesium sulphate intramuscular in?

Magnesium sulphate intramuscular is FDA-approved (marketed).

What are the side effects of Magnesium sulphate intramuscular?

Common side effects of Magnesium sulphate intramuscular include Flushing, Sweating, Hypotension, Depressed reflexes, Muscle weakness, Respiratory depression.

What does Magnesium sulphate intramuscular target?

Magnesium sulphate intramuscular targets NMDA receptor; voltage-gated calcium channels and is a Anticonvulsant; electrolyte supplement.

Related